- £1.06bn
- -£989.98m
- £144.90m
- 74
- 54
- 40
- 58
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 18.51 | ||
| PEG Ratio (f) | 3.52 | ||
| EPS Growth (f) | 5.55% | ||
| Dividend Yield (f) | 3.57% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.15 | ||
| Price to Tang. Book | 5.51 | ||
| Price to Free Cashflow | 3.11 | ||
| Price to Sales | 6.97 | ||
| EV to EBITDA | -15.11 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 25.66% | ||
| Return on Equity | 24.7% | ||
| Operating Margin | 41.07% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 107.32 | 123.67 | 133.6 | 134.9 | 144.9 | 155.69 | 166.53 | 7.88% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +10.98 | +12.25 | +0.74 | -2.66 | +5.26 | +3.08 | +6.38 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
IntegraFin Holdings plc is a United Kingdom-based investment platform company. The Company is an operator of Transact, the United Kingdom’s investment platform for clients and the United Kingdom financial advisers. The Company operates through three segments: Investment administration services segment comprises services performed by Integrated Financial Arrangements Ltd (IFAL), which is the provider of the Transact wrap service; Insurance and life assurance business segment comprises IntegraLife UK Limited (ILUK) and IntegraLife International Limited (ILInt), insurance companies which provide the Transact Personal Pension, Executive Pension, Section 32 Buy-Out Bond, Transact Onshore and Offshore Bonds, and Qualifying Savings Plan on the Transact platform; Adviser back-office technology segment comprises Time4Advice (T4A), provider of financial planning technology to adviser and wealth management firms via the CURO adviser support system.
Directors
- Richard Cranfield NEC
- Alexander Scott CEO
- Jonathan Gunby EDR
- Michael Howard EDR
- Helen Wakeford SEC
- Victoria Cochrane NED (64)
- Caroline Banszky NID
- Rita Dhut NID
- Robert Lister NID
- Christopher Munro NID (69)
- Last Annual
- September 30th, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- January 24th, 2014
- Public Since
- February 27th, 2018
- No. of Employees
- 675
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
London Stock Exchange- Shares in Issue
- 331,322,014
- Address
- 29 Clement's Lane, LONDON, EC4N 7AE
- Web
- https://www.integrafin.co.uk/
- Phone
- +44 2076084900
- Contact
- Luke Carrivick
- Auditors
- Ernst & Young LLP
Latest News for IHP
Upcoming Events for IHP
Q3 2025 IntegraFin Holdings plc Trading Statement Release
Q4 2025 IntegraFin Holdings plc Trading Statement Release
Full Year 2025 IntegraFin Holdings plc Earnings Release
Similar to IHP
3i
London Stock Exchange
450
London Stock Exchange
Aberdeen
London Stock Exchange
Achilles Investment Co
London Stock Exchange
Agronomics
London Stock Exchange
FAQ
As of Today at 21:19 UTC, shares in Integrafin Holdings are trading at 319.00p. This share price information is delayed by 15 minutes.
Shares in Integrafin Holdings last closed at 319.00p and the price had moved by -9.5% over the past 365 days. In terms of relative price strength the Integrafin Holdings share price has underperformed the FTSE All Share Index by -15.95% over the past year.
The overall consensus recommendation for Integrafin Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Integrafin Holdings dividend yield is 3.29% based on the trailing twelve month period.
Last year, Integrafin Holdings paid a total dividend of £0.11, and it currently has a trailing dividend yield of 3.29%.Looking ahead, the next dividend pay date is 2025-07-04.
We do not have data on when Integrafin Holdings is to next pay dividends. The historic dividend yield on Integrafin Holdings shares is currently 3.29%.
To buy shares in Integrafin Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 319.00p, shares in Integrafin Holdings had a market capitalisation of £1.06bn.
Here are the trading details for Integrafin Holdings:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: IHP
Based on an overall assessment of its quality, value and momentum Integrafin Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Integrafin Holdings is 357.42p. That is 12.04% above the last closing price of 319.00p.
Analysts covering Integrafin Holdings currently have a consensus Earnings Per Share (EPS) forecast of £0.16 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Integrafin Holdings. Over the past six months, its share price has underperformed the FTSE All Share Index by -15.02%.
As of the last closing price of 319.00p, shares in Integrafin Holdings were trading -7.19% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Integrafin Holdings PE ratio based on its reported earnings over the past 12 months is 18.51. The shares last closed at 319.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Integrafin Holdings' management team is headed by:
- Richard Cranfield - NEC
- Alexander Scott - CEO
- Jonathan Gunby - EDR
- Michael Howard - EDR
- Helen Wakeford - SEC
- Victoria Cochrane - NED
- Caroline Banszky - NID
- Rita Dhut - NID
- Robert Lister - NID
- Christopher Munro - NID